前收市價 | 7.20 |
開市 | 7.20 |
買盤 | 3.50 |
賣出價 | 6.50 |
拍板 | 20.00 |
到期日 | 2024-06-21 |
今日波幅 | 7.20 - 7.20 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 214 |
Repligen (RGEN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
AnaptysBio (ANAB) delivered earnings and revenue surprises of -6.49% and 57.78%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
AnaptysBio (ANAB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.